Skip to content
Trial Eligibility
Menu

Lung Cancer Clinical Trials near Atlanta, GA

84 studies for Lung Cancer are recruiting at 158 sites within 50 miles of Atlanta, Georgia, according to ClinicalTrials.gov data processed .

Distances are city-level approximations. See all Lung Cancer trials in the US or all trials near Atlanta.

Your ZIP is looked up in your browser. We don't receive or store it.

Recruiting now

Lung Cancer studies enrolling near Atlanta

Showing the 50 nearest of 84 studies.
  1. Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancer

    NCT03851445

    • Phase 2/3
    • Ages 18 years and older
    • Sex: All

    Nearest sites: Emory Saint Joseph's Hospital (Atlanta, GA); Emory University Hospital Midtown (Atlanta, GA)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    14 sites within 50 mi
  2. Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)

    NCT06616584

    • Phase 2/3
    • Ages 18 years and older
    • Sex: All

    Nearest sites: Emory Saint Joseph's Hospital (Atlanta, GA); Emory University Hospital Midtown (Atlanta, GA)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    11 sites within 50 mi
  3. Testing the Addition of High Dose, Targeted Radiation to the Usual Treatment for Locally-Advanced Inoperable Non-Small Cell Lung Cancer

    NCT05624996

    • Phase 3
    • Ages 18 years and older
    • Sex: All

    Nearest sites: Emory Proton Therapy Center (Atlanta, GA); Emory Saint Joseph's Hospital (Atlanta, GA)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    8 sites within 50 mi
  4. LOTUS-CC: An Observational Research Study to Uncover Subtypes of Cancer Cachexia

    NCT06073431

    • Observational
    • Ages 18 years and older
    • Sex: All

    Nearest sites: Northside Hospital (Atlanta, GA); Northside Hospital - Duluth (Duluth, GA)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    6 sites within 50 mi
  5. Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial

    NCT06498635

    • Phase 3
    • Ages 18 years and older
    • Sex: All

    Nearest sites: Emory Saint Joseph's Hospital (Atlanta, GA); Emory University Hospital Midtown (Atlanta, GA)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    5 sites within 50 mi
  6. A Study of Amivantamab in Combination With Lazertinib, or Amivantamab in Combination With Platinum-Based Chemotherapy, for Common Epidermal Growth Factor Receptor (EGFR)-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)

    NCT06667076

    • Phase 2
    • Ages 18 years and older
    • Sex: All

    Nearest sites: Grady Health System Correll Pavilion (Atlanta, GA); Piedmont Cancer Institute (Atlanta, GA)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    5 sites within 50 mi
  7. Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])

    NCT04267848

    • Phase 3
    • Ages 18 years and older
    • Sex: All

    Nearest sites: Northside Hospital (Atlanta, GA); Northside Hospital - Duluth (Duluth, GA)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    4 sites within 50 mi
  8. Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)

    NCT05642572

    • Phase 2
    • Ages 18 years and older
    • Sex: All

    Nearest sites: Northside Hospital (Atlanta, GA); Northside Hospital - Duluth (Duluth, GA)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    4 sites within 50 mi
  9. A Study to Assess Efficacy and Safety of Pembrolizumab With or Without Sacituzumab Tirumotecan (MK- 2870) in Adult Participants With Resectable Non Small Cell Lung Cancer (NSCLC) Not Achieving Pathological Complete Response (pCR) (MK-2870-019)

    NCT06312137

    • Phase 3
    • Ages 18 years and older
    • Sex: All

    Nearest sites: Emory University School of Medicine-Phase I ( Site 0056) (Atlanta, GA); Northside Hospital ( Site 0055) (Atlanta, GA)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    4 sites within 50 mi
  10. Testing Osimertinib as a Treatment for Lung Cancers With an EGFR Exon 20 Change

    NCT03191149

    • Phase 2
    • Ages 18 years and older
    • Sex: All

    Nearest sites: Emory Saint Joseph's Hospital (Atlanta, GA); Emory University Hospital Midtown (Atlanta, GA)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    3 sites within 50 mi
  11. Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has Increased Copies of the MET Gene (An Expanded Lung-MAP Treatment Trial)

    NCT06116682

    • Phase 2
    • Ages 18 years and older
    • Sex: All

    Nearest sites: Emory University Hospital Midtown (Atlanta, GA); Emory University Hospital/Winship Cancer Institute (Atlanta, GA)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    3 sites within 50 mi
  12. Testing the Combination of an Anti-cancer Drug, Iadademstat, With Other Anti-cancer Drugs (Atezolizumab or Durvalumab) at Improving Outcomes for Small Cell Lung Cancer

    NCT06287775

    • Phase 1/2
    • Ages 18 years and older
    • Sex: All

    Nearest sites: Emory Saint Joseph's Hospital (Atlanta, GA); Emory University Hospital Midtown (Atlanta, GA)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    3 sites within 50 mi
  13. Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics

    NCT06418204

    • Observational
    • Ages 18 years and older
    • Sex: All

    Nearest sites: Northside Hospital (Atlanta, GA); Northside Hospital - Duluth (Duluth, GA)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    3 sites within 50 mi
  14. Osimertinib With or Without Bevacizumab as Initial Treatment for Patients With EGFR-Mutant Lung Cancer

    NCT04181060

    • Phase 3
    • Ages 18 years and older
    • Sex: All

    Nearest sites: Emory University Hospital Midtown (Atlanta, GA); Emory University Hospital/Winship Cancer Institute (Atlanta, GA)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    2 sites within 50 mi
  15. GEMINI-NSCLC: NSCLC Biomarker Study

    NCT05236114

    • Observational
    • Ages 18 years and older
    • Sex: All

    Nearest sites: Morehouse School of Medicine (MSM) (Atlanta, GA); Piedmont Healthcare (Atlanta, GA)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    2 sites within 50 mi
  16. A Phase 1/2a Study of DB-1311/BNT324 in Advanced/Metastatic Solid Tumors

    NCT05914116

    • Phase 1/2
    • Ages 18 years and older
    • Sex: All

    Nearest sites: Research Site 114 (Atlanta, GA); Research Site 139 (Atlanta, GA)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    2 sites within 50 mi
  17. A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer

    NCT06119581

    • Phase 3
    • Ages 18 years and older
    • Sex: All

    Nearest sites: Emory University School of Medicine- Grady Campus (Atlanta, GA); Winship Cancer Institute, Emory University (Atlanta, GA)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    2 sites within 50 mi
  18. Phase III, Open-label, Study of First-line Dato-DXd in Combination With Rilvegostomig for Advanced Non-squamous NSCLC With High PD-L1 Expression (TC ≥ 50%) and Without Actionable Genomic Alterations

    NCT06357533

    • Phase 3
    • Ages 18 years and older
    • Sex: All

    Nearest sites: Research Site (Atlanta, GA); Research Site (Atlanta, GA)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    2 sites within 50 mi
  19. Defactinib, Avutometinib and Nivolumab for the Treatment of Anti-PD1 Refractory LKB1-Mutant Advanced Non-Small Cell Lung Cancer

    NCT06495125

    • Phase 2
    • Ages 18 years and older
    • Sex: All

    Nearest sites: Emory Saint Joseph's Hospital (Atlanta, GA); Emory University Hospital/Winship Cancer Institute (Atlanta, GA)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    2 sites within 50 mi
  20. Diclofenac for the Treatment of Patients With Metastatic Non-small Cell Lung Cancer on Single Agent Immunotherapy

    NCT06731270

    • Phase 2
    • Ages 18 years and older
    • Sex: All

    Nearest sites: Emory University Hospital Midtown (Atlanta, GA); Emory University Hospital/Winship Cancer Institute (Atlanta, GA)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    2 sites within 50 mi
  21. A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carboplatin or Cisplatin in Participants With Previously Untreated, KRAS G12C-Mutated, Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer

    NCT06793215

    • Phase 3
    • Ages 18 years and older
    • Sex: All

    Nearest sites: Piedmont Cancer Institute, PC (Atlanta, GA); City of Hope® Atlanta (Newnan, GA)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    2 sites within 50 mi
  22. Study of Daraxonrasib (RMC-6236) in Patients With RAS Mutated NSCLC (RASolve 301)

    NCT06881784

    • Phase 3
    • Ages 18 years and older
    • Sex: All

    Nearest sites: Piedmont Healthcare, Inc (Atlanta, GA); Winship Cancer Institute (Atlanta, GA)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    2 sites within 50 mi
  23. Beamion LUNG-3: Adjuvant Zongertinib vs Standard Treatment in People With Completely Resected Stage II-IIIB NSCLC Harboring Activating HER2 TKD Mutations

    NCT07195695

    • Phase 3
    • Ages 18 years and older
    • Sex: All

    Nearest sites: Piedmont Cancer Institute (Atlanta, GA); Northwest Georgia Oncology Centers (Marietta, GA)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    2 sites within 50 mi
  24. SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

    NCT03452774

    • Observational
    • Ages Any age
    • Sex: All

    Nearest site: Massive Bio SYNERGY-AI site (Atlanta, GA)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  25. A Study of Bispecific Antibody MCLA-158 in Patients With Advanced Solid Tumors

    NCT03526835

    • Phase 1/2
    • Ages 18 years and older
    • Sex: All

    Nearest site: Emory University (Atlanta, GA)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  26. Study of INBRX-106 and INBRX-106 in Combination With Pembrolizumab (Keytruda®) in Subjects With Locally Advanced or Metastatic Solid Tumors (Hexavalent OX40 Agonist)

    NCT04198766

    • Phase 1/2
    • Ages 18 years and older
    • Sex: All

    Nearest site: Winship Cancer Institute - Emory University (Atlanta, GA)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  27. Prospective Study of Intensity-Modulated Proton Therapy (IMPT) for Small Cell Lung Cancer

    NCT04342429

    • Interventional
    • Ages 18 years and older
    • Sex: All
    • Accepts healthy volunteers

    Nearest site: Winship Cancer Institute (Atlanta, GA)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  28. MRX-2843 and Osimertinib for the Treatment of Advanced EGFR Mutant Non-small Cell Lung Cancer

    NCT04762199

    • Phase 1
    • Ages 18 years and older
    • Sex: All

    Nearest site: Emory University Hospital/Winship Cancer Institute (Atlanta, GA)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  29. Study of STK-012 Alone and With Other Treatments in Patients With Advanced Lung Cancer and Other Cancers

    NCT05098132

    • Phase 1/2
    • Ages 18 years and older
    • Sex: All

    Nearest site: Winship Cancer Institute, Emory University (Atlanta, GA)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  30. Palliative Radiotherapy With Lurbinectedin in Patients With Extensive Stage Small Cell Lung Cancer

    NCT05244239

    • Phase 1
    • Ages 18 years and older
    • Sex: All

    Nearest site: Emory University (Atlanta, GA)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  31. Study of RMC-6236 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS

    NCT05379985

    • Phase 1/2
    • Ages 18 years and older
    • Sex: All

    Nearest site: Piedmont Healthcare (Atlanta, GA)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  32. Study of XmAb®819 in Subjects With Advanced Clear Cell Renal Cell Carcinoma

    NCT05433142

    • Phase 1
    • Ages 18 years and older
    • Sex: All

    Nearest site: Xencor Investigative Site (Atlanta, GA)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  33. Low-Dose Interleukin-2 and Pembrolizumab for the Treatment of Stage IV Non-Small Cell Lung Cancer

    NCT05493566

    • Early Phase 1
    • Ages 18 years and older
    • Sex: All

    Nearest site: Emory University/Winship Cancer Institute (Atlanta, GA)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  34. A Study of DB-1310 in Advanced/Metastatic Solid Tumors

    NCT05785741

    • Phase 1/2
    • Ages 18 years and older
    • Sex: All

    Nearest site: Research Site 111 (Atlanta, GA)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  35. Proton Beam Radiation Therapy After Treatment for Resected N2 Non-Small Cell Lung Cancer

    NCT06008730

    • Phase 2
    • Ages 18 years and older
    • Sex: All

    Nearest site: Emory University Hospital/Winship Cancer Institute (Atlanta, GA)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  36. A Phase 1 Study of PLN-101095 in Adults With Advanced or Metastatic Solid Tumors

    NCT06270706

    • Phase 1
    • Ages 18 years and older
    • Sex: All

    Nearest site: Winship Cancer Institute of Emory University (Atlanta, GA)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  37. A Study to Learn More About How Well Sevabertinib Works and How Safe it is Compared With Standard Treatment, in Participants Who Have Advanced Non-small Cell Lung Cancer (NSCLC) With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)

    NCT06452277

    • Phase 3
    • Ages 18 years and older
    • Sex: All

    Nearest site: Piedmont Healthcare - Atlanta (Atlanta, GA)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  38. Study of XB010 in Subjects With Solid Tumors

    NCT06545331

    • Phase 1
    • Ages 18 years and older
    • Sex: All

    Nearest site: Winship Cancer Institute (Atlanta, GA)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  39. Safety, PK and Efficacy of QXL138AM in Patients With Solid Tumors and Multiple Myeloma

    NCT06582017

    • Phase 1
    • Ages 18 years and older
    • Sex: All

    Nearest site: Emory University - Winship Cancer Institute (Atlanta, GA)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  40. MOONRAY-01, A Study of LY3962673 in Participants With KRAS G12D-Mutant Solid Tumors

    NCT06586515

    • Phase 1
    • Ages 18 years and older
    • Sex: All

    Nearest site: Emory University School of Medicine (Atlanta, GA)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  41. A Study With NKT3964 for Adults With Advanced/Metastatic Solid Tumors

    NCT06586957

    • Phase 1
    • Ages 19 years and older
    • Sex: All

    Nearest site: Emory Winship Cancer Institute (Atlanta, GA)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  42. Pan-tumor MRD Study

    NCT06605404

    • Observational
    • Ages 18 years and older
    • Sex: All

    Nearest site: Piedmont Cancer Institute (Atlanta, GA)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  43. A Study of JNJ-90301900 in Combination With Chemoradiation Followed by Consolidation Immunotherapy for Non-Small Cell Lung Cancer (NSCLC)

    NCT06667908

    • Phase 2
    • Ages 18 years and older
    • Sex: All

    Nearest site: Emory University Winship Cancer Institute (Atlanta, GA)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  44. Safety and Efficacy of BNT327, an Investigational Therapy in Combination With Chemotherapy for Patients With Untreated Small-cell Lung Cancer

    NCT06712355

    • Phase 3
    • Ages 18 years and older
    • Sex: All

    Nearest site: Northside Hospital Atlanta (Atlanta, GA)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  45. Clinical Trial of N-803 Plus Tislelizumab or Prior Failed Immune Checkpoint Inhibitor and Docetaxel Versus Docetaxel Monotherapy in Participants With Advanced or Metastatic Non-Small Cell Lung Cancer Who Have Acquired Resistance to Immune Checkpoint In

    NCT06745908

    • Phase 3
    • Ages 18 to 90 years
    • Sex: All

    Nearest site: Emory University - Winship Cancer Institute (Atlanta, GA)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  46. Neladalkib (NVL-655) for TKI-naive Patients With Advanced ALK-Positive NSCLC

    NCT06765109

    • Phase 3
    • Ages 18 years and older
    • Sex: All

    Nearest site: Winship Cancer Institute of Emory University (Atlanta, GA)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  47. Clinical Study of Ivonescimab for First-line Treatment of Metastatic NSCLC Patients With High PD-L1

    NCT06767514

    • Phase 3
    • Ages 18 years and older
    • Sex: All

    Nearest site: Clinical Study Site (Atlanta, GA)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  48. Study of Olomorasib (LY3537982) in Combination With Standard of Care in Participants With Resected or Unresectable KRAS G12C-mutant Non-Small Cell Lung Cancer

    NCT06890598

    • Phase 3
    • Ages 18 years and older
    • Sex: All

    Nearest site: Winship Cancer Institute (Atlanta, GA)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  49. Study of Trastuzumab Deruxtecan, Pembrolizumab, and Platinum-based Chemotherapy in First-line HER2 Overexpressing Non-small Cell Lung Cancer

    NCT06899126

    • Phase 3
    • Ages 18 years and older
    • Sex: All

    Nearest site: Piedmont Cancer Institute OneOncology (Atlanta, GA)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  50. DB-1311 in Combination With BNT327 or DB-1305 in Advanced/Metastatic Solid Tumors

    NCT06953089

    • Phase 2
    • Ages 18 years and older
    • Sex: All

    Nearest site: USA10-0 (Atlanta, GA)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi

FAQ

Common questions

What is a clinical trial?
A clinical trial is a research study in people that tests a medical, surgical or behavioral intervention, such as an investigational drug or device. Observational studies are also listed: they collect information without assigning a treatment. Read how clinical trials work.
Is there compensation for joining a Lung Cancer clinical trial?
Compensation for time and travel may be available, but it varies by study and some studies offer none. The amount and schedule are reviewed by an ethics board and described in the consent form. See compensation in clinical trials.
How do I check if I'm eligible?
Each study lists age, sex and other inclusion and exclusion criteria on its ClinicalTrials.gov record. Only the study team can confirm eligibility, usually through a screening call or visit. Talk with your own doctor before joining any study.

Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.